Might be 10 might be 12 or 15 . There isn't a number per se as...

Might be 10 might be 12 or 15 . There isn't a number per se as its whatever number of cohorts that the data and its outcomes are deemed statistically reliable. This is a very important aspect of the trial. We want to convince the deep pockets around the corner of this prior to the large scale trial required for FDA approval. It will wrap up in the next few months is my guess. Remember other important tweaking of dosage size etc to optimise things is also going on. Behind all this negativity there is a lot going on in the background. Yes its a punt to some extent but t believe we are not far away from a rapid change in trajectory for IBX . Good luck to all